Sign in

CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company

Amylyx Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464600503
Phone
617-682-0917
Business address
55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
  1. 8-K Event Results of operations
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 4 Open-market sale 10% owner sold 60,609 shares at an average $20.70 ($1,254,642)
  5. 8-K Event Other events
  6. SC 13G Stake Amended Statement of Ownership
  7. 8-K Event Other events
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Shareholder vote results
  13. 8-K Event Other events
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 4 Option exercise Co-Chief Executive Officer acquired 334,520 shares (option exercise)
  17. 4 Option exercise Co-Chief Executive Officer acquired 334,520 shares (option exercise)
  18. 4 Conversion 10% owner acquired 5,955,889 shares (conversion)
  19. 3 Insider Initial Statement of Ownership
  20. DEFA14A Proxy Proxy Materials

Page 19 of 23 · 446 filings